Скачать книгу

rel="nofollow" href="#ulink_19caef86-7b7d-59e5-a389-e54d0b5b0a16">Table 17.3).

      Changes in gastric motor function related to ageing

Acute
Drugs (opiates, anticholinergics, L‐dopa)
Postoperative ileus
Viral gastroenteritis
Metabolic (hyperglycaemia, hypokalaemia)
Critical illness
Chronic
Idiopathic/Functional dyspepsia
Diabetes
Post‐surgical (including fundoplication)
GORD
Chronic liver disease
HIV infection
Other endocrine and metabolic (hypothyroidism, chronic renal failure, anorexia nervosa)
Muscular and connective tissue diseases (myotonic dystrophy, muscular dystrophy, dermatomyositis, systemic sclerosis, amyloidosis, tumour‐associated)
Neurological (central nervous system disease, spinal cord injury, chronic idiopathic intestinal pseudo‐obstruction, idiopathic autonomic degeneration)
Decreased motility or gut transit
Opiates
Anticholinergics
GLP‐1 receptor agonists
L‐dopa
Tricyclic antidepressants
Calcium channel antagonists
Nitrates
Phosphodiesterase type 5 inhibitors (e.g. sildenafil)
Clonidine (an α‐2 agonist)
Sumatriptan (a 5‐HT‐1P agonist)a
Increased motility or gut transit
Metoclopramide
Domperidone
Erythromycin (a motilin agonist)b
Prucalopride
Beta blockers
Selective serotonin reuptake inhibitors
Cholinesterase inhibitors
Excess thyroxine

      a Relaxes the gastric fundus and slows gastric emptying but increases oesophageal motility.

      b Stimulates gastric emptying but slows small‐intestinal transit.

Photo depicts scintigraphic gastric emptying study.